Literature DB >> 11943393

Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

L Mu1, S S Feng.   

Abstract

The D-alpha-tocopheryl polyethylene glycol 1000 succinate (vitamin E TPGS) was applied in the present investigation as surfactant stabiliser to fabricate paclitaxel-loaded PLGA nanospheres in the solvent evaporation/extraction technique with successful achievement. Laser light scattering system (LLS), scanning electron microscopy (SEM), atomic force microscopy (AFM), differential scanning calorimetry (DSC), Fourier transform infra-red spectroscopy (FTIR), and X-ray photoelectron spectroscopy (XPS) were employed to characterise the nanopsheres fabricated in various recipes under various preparation conditions for size and size distribution, surface morphology, thermogram property and surface chemistry. Encapsulation efficiency and in vitro release was measured by the high-performance liquid chromatography (HPLC). The outcomes were discussed with respect to the development of polymeric nanospheres delivery system of the anticancer drug, paclitaxel (Taxol((R))). The produced nanospheres were found in fine spherical shape with smooth surfaces and without aggregation or adhesion. There was no significant difference in morphology between the vitamin E TPGS emulsified and PVA emulsified PLGA nanospheres. However, it was found that, in comparison with the traditional chemical emulsifier PVA, the TPGS could significantly improve the encapsulation efficiency of the drug in the PLGA nanospheres, which could be as high as 100%. The size of the vitamin E TPGS emulsified nanospheres ranged from 300 to 800 nm and the size distribution was narrow with polydispersity of 0.005-0.045. XPS investigation demonstrated that there were residual surfactant molecules remained on the surface although the TPGS could be washed out relatively thoroughly in the process of nanospheres formation. This finding was also confirmed by FTIR-PAS investigation of the nanospheres. The in vitro release indicated that the release property of paclitaxel from the nanospheres strongly depends on the emulsifier type employed in the fabrication. Our research shows that vitamin E TPGS could be an ideal and effective emulsifier.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943393     DOI: 10.1016/s0168-3659(02)00025-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  53 in total

1.  Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy.

Authors:  Sinjan De; Dennis H Robinson
Journal:  AAPS PharmSciTech       Date:  2004-09-13       Impact factor: 3.246

Review 2.  Advances in the use of tocols as drug delivery vehicles.

Authors:  Panayiotis P Constantinides; Jihong Han; Stanley S Davis
Journal:  Pharm Res       Date:  2006-01-25       Impact factor: 4.200

3.  Development and characterization of lyophilized diazepam-loaded polymeric micelles.

Authors:  Jiraphong Suksiriworapong; Tanaporn Rungvimolsin; Atitaya A-gomol; Varaporn Buraphacheep Junyaprasert; Doungdaw Chantasart
Journal:  AAPS PharmSciTech       Date:  2013-10-03       Impact factor: 3.246

4.  A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery.

Authors:  Xiaojuan Yang; Yong Peng; Bo Yu; Jianhua Yu; Chenguang Zhou; Yicheng Mao; L James Lee; Robert J Lee
Journal:  Mol Pharm       Date:  2011-03-23       Impact factor: 4.939

5.  A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.

Authors:  Olcay Mert; Samuel K Lai; Laura Ensign; Ming Yang; Ying-Ying Wang; Joseph Wood; Justin Hanes
Journal:  J Control Release       Date:  2011-09-03       Impact factor: 9.776

6.  Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation.

Authors:  Mengyuan Zhang; Jianhua He; Wenli Zhang; Jianping Liu
Journal:  Pharm Res       Date:  2018-08-30       Impact factor: 4.200

7.  Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.

Authors:  Sneha A Kulkarni; Si-Shen Feng
Journal:  Pharm Res       Date:  2013-01-12       Impact factor: 4.200

8.  Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.

Authors:  Yichao Wang; Puwang Li; Lingxue Kong
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

9.  Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.

Authors:  Thulani H Senanayake; Galya Warren; Xin Wei; Serguei V Vinogradov
Journal:  J Control Release       Date:  2013-02-04       Impact factor: 9.776

10.  Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel.

Authors:  Primiano Pio Di Mauro; Salvador Borrós
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.